{"id":31001,"date":"2026-03-12T21:36:07","date_gmt":"2026-03-12T21:36:07","guid":{"rendered":"https:\/\/www.europesays.com\/ch\/31001\/"},"modified":"2026-03-12T21:36:07","modified_gmt":"2026-03-12T21:36:07","slug":"12-health-care-stocks-moving-in-thursdays-after-market-session-alps-group-nasdaqalps-co-diagnostics-nasdaqcodx","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch\/31001\/","title":{"rendered":"12 Health Care Stocks Moving In Thursday&#8217;s After-Market Session &#8211; ALPS Group (NASDAQ:ALPS), Co-Diagnostics (NASDAQ:CODX)"},"content":{"rendered":"<p>Gainers<br \/>\niSpecimen (NASDAQ:<a class=\"ticker\" href=\"https:\/\/www.benzinga.com\/quote\/ISPC\" target=\"_blank\" rel=\"nofollow noopener\">ISPC<\/a>) shares moved upwards by 70.7% to $0.38 during Thursday&#8217;s after-market session. The market value of their outstanding shares is at $2.3 million.<br \/>\nOncology Institute (NASDAQ:<a class=\"ticker\" href=\"https:\/\/www.benzinga.com\/quote\/TOI\" target=\"_blank\" rel=\"nofollow noopener\">TOI<\/a>) shares increased by 13.74% to $2.98. The company&#8217;s market cap stands at $271.5 million. As per the press release, Q4 earnings came out today.<br \/>\nCo-Diagnostics (NASDAQ:<a class=\"ticker\" href=\"https:\/\/www.benzinga.com\/quote\/CODX\" target=\"_blank\" rel=\"nofollow noopener\">CODX<\/a>) shares moved upwards by 13.3% to $2.98. The market value of their outstanding shares is at $6.7 million.<br \/>\nCoya Therapeutics (NASDAQ:<a class=\"ticker\" href=\"https:\/\/www.benzinga.com\/quote\/COYA\" target=\"_blank\" rel=\"nofollow noopener\">COYA<\/a>) stock moved upwards by 8.84% to $5.17. The company&#8217;s market cap stands at $103.1 million.<br \/>\nPhreesia (NYSE:<a class=\"ticker\" href=\"https:\/\/www.benzinga.com\/quote\/PHR\" target=\"_blank\" rel=\"nofollow noopener\">PHR<\/a>) shares increased by 8.29% to $11.91. The market value of their outstanding shares is at $683.6 million.<br \/>\nALPS Group (NASDAQ:<a class=\"ticker\" href=\"https:\/\/www.benzinga.com\/quote\/ALPS\" target=\"_blank\" rel=\"nofollow noopener\">ALPS<\/a>) stock moved upwards by 6.89% to $1.24. The company&#8217;s market cap stands at $161.4 million.<br \/>\nLosers<\/p>\n<p class=\"block core-block\">This article was generated by Benzinga&#8217;s automated content engine and reviewed by an editor.<\/p>\n<p><a class=\"text-sm my-4\" href=\"https:\/\/www.benzinga.com\/apis?utm_source=benzinga.com&amp;utm_campaign=article-bottom\" rel=\"noreferrer nofollow noopener\" target=\"_blank\">Market News and Data brought to you by Benzinga APIs<\/a><\/p>\n<p class=\"copyright\">\u00a9 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.<\/p>\n<p class=\"block core-block\">To add Benzinga News as your preferred source on Google, <a href=\"https:\/\/google.com\/preferences\/source?q=https%3A%2F%2Fwww.benzinga.com\" rel=\"noreferrer nofollow noopener\" target=\"_blank\">click here<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"Gainers iSpecimen (NASDAQ:ISPC) shares moved upwards by 70.7% to $0.38 during Thursday&#8217;s after-market session. The market value of&hellip;\n","protected":false},"author":2,"featured_media":31002,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16],"tags":[50,346,8230,340,18625,18626,18627,18628,18629,18630,18631,18632,18633,18634,18635,18636,18637],"class_list":{"0":"post-31001","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-alps","8":"tag-alps","9":"tag-category-movers","10":"tag-cms-drupal","11":"tag-pageisbzpro-bz","12":"tag-symbol-alps","13":"tag-symbol-codx","14":"tag-symbol-coya","15":"tag-symbol-hcat","16":"tag-symbol-ispc","17":"tag-symbol-krro","18":"tag-symbol-lnai","19":"tag-symbol-phr","20":"tag-symbol-snes","21":"tag-symbol-sprc","22":"tag-symbol-toi","23":"tag-symbol-worx","24":"tag-tag-bzi-tfm"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ch\/116218362884203680","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/31001","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=31001"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/31001\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/31002"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=31001"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=31001"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=31001"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}